stock logo

100% Buy

ORCHID PHARMA Share Price

ORCHPHARMA

₹1,389.65-₹55.60 (-3.85%) TodayLast updated on 04 Nov, 2024 | 15:55 IST

ORCHID PHARMA Share Price Chart

Please wait...
  • About ORCHID PHARMA
  • Fundamentals
  • More
  • News

About ORCHID PHARMA

ORCHID PHARMA Financials

arrow
Market cap
Market Cap Switch₹7,394 Crs
Open
₹1,465.00
Close
₹1,445.25
Circuit range
₹1,667.55 - ₹1,111.75
Day range
₹1,375.95 - ₹1,465.00
Year range
₹492.80 - ₹1,590.00
Volume
63,624
Avg. traded
₹1,399.39
Revenue (12m)
₹881 Crs
ORCHID PHARMAOrchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

Orchid Pharma Key indicators

arrow
52 week high
₹1,590.00
52 week low
₹492.80
P/E ratio
63.7
P/B ratio
5.54
ROE
9.72%
ROCE
8.96%
Dividend yield
--
Debt/Equity ratio
0.11
EPS
18.68

Learn more

Investment checklist: (2/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 3 experts in the last 7 days

ORCHID PHARMA Fundamentals

ORCHID PHARMA Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

17.26%

Net profit margin

11.56%

ROE

9.72%

ROA

6.83%

ROCE

8.96%

Learn more

ORCHID PHARMA Shareholder returns

arrow
1 day
-3.85%
1 week
+8.29%
1 month
+8.22%
3 months
-1.98%
1 year
+182.59%
3 years
+238.24%
5 years
+7620.28%

Orchid Pharma Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹1,465.00
₹1,389.65
-3.85%
Fri, Nov 1 2024
₹1,468.80
₹1,445.25
-0.86%
Thu, Oct 31 2024
₹1,400.90
₹1,457.85
+4.79%
Wed, Oct 30 2024
₹1,316.90
₹1,391.15
+6.17%
Tue, Oct 29 2024
₹1,278.00
₹1,310.35
+2.11%
Mon, Oct 28 2024
₹1,264.65
₹1,283.25
+2.27%
Fri, Oct 25 2024
₹1,323.80
₹1,254.75
-5.22%
Thu, Oct 24 2024
₹1,284.05
₹1,323.80
+3.41%

ORCHID PHARMA Shareholding Pattern

arrow

Promoters (69.84%)

Mutual Funds (16.91%)

Retail and other (9.81%)

Foreign institutions-FII (1.42%)

Other domestic institutions (2.02%)

Promoters

Learn more

FAQs on ORCHID PHARMA